These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 15495098)

  • 1. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
    Schieppati A; Perna A; Zamora J; Giuliano GA; Braun N; Remuzzi G
    Cochrane Database Syst Rev; 2004 Oct; (4):CD004293. PubMed ID: 15495098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
    Chen Y; Schieppati A; Chen X; Cai G; Zamora J; Giuliano GA; Braun N; Perna A
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004293. PubMed ID: 25318831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
    von Groote TC; Williams G; Au EH; Chen Y; Mathew AT; Hodson EM; Tunnicliffe DJ
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD004293. PubMed ID: 34778952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Habashy D; Hodson E; Craig J
    Cochrane Database Syst Rev; 2004; (2):CD003594. PubMed ID: 15106208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Hodson EM; Habashy D; Craig JC
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003594. PubMed ID: 16625586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis.
    Ren S; Wang Y; Xian L; Toyama T; Jardine M; Li G; Perkovic V; Hong D
    PLoS One; 2017; 12(9):e0184398. PubMed ID: 28898290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive treatment for nephrotic idiopathic membranous nephropathy: a meta-analysis based on Chinese adults.
    Xie G; Xu J; Ye C; Chen D; Xu C; Yang L; Ma Y; Hu X; Li L; Sun L; Zhao X; Mao Z; Mei C
    PLoS One; 2012; 7(9):e44330. PubMed ID: 22957065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Hodson EM; Willis NS; Craig JC
    Cochrane Database Syst Rev; 2010 Nov; (11):CD003594. PubMed ID: 21069676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Hodson EM; Wong SC; Willis NS; Craig JC
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD003594. PubMed ID: 27726125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of 13 immunosuppressive agents for idiopathic membranous nephropathy in adults with nephrotic syndrome: a systematic review and network meta-analysis.
    Zheng Q; Yang H; Liu W; Sun W; Zhao Q; Zhang X; Jin H; Sun L
    BMJ Open; 2019 Sep; 9(9):e030919. PubMed ID: 31511292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tripterygium wilfordii Hook F (a traditional Chinese medicine) for primary nephrotic syndrome.
    Chen Y; Gong Z; Chen X; Tang L; Zhao X; Yuan Q; Cai G
    Cochrane Database Syst Rev; 2013 Aug; (8):CD008568. PubMed ID: 23934958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-corticosteroid treatment for nephrotic syndrome in children.
    Durkan A; Hodson E; Willis N; Craig J
    Cochrane Database Syst Rev; 2001; (4):CD002290. PubMed ID: 11687155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.
    Pravitsitthikul N; Willis NS; Hodson EM; Craig JC
    Cochrane Database Syst Rev; 2013 Oct; (10):CD002290. PubMed ID: 24166716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-corticosteroid treatment for nephrotic syndrome in children.
    Hodson EM; Willis NS; Craig JC
    Cochrane Database Syst Rev; 2008 Jan; (1):CD002290. PubMed ID: 18254005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive treatment for idiopathic membranous nephropathy: a systematic review.
    Perna A; Schieppati A; Zamora J; Giuliano GA; Braun N; Remuzzi G
    Am J Kidney Dis; 2004 Sep; 44(3):385-401. PubMed ID: 15332211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions for preventing infection in nephrotic syndrome.
    Wu HM; Tang JL; Sha ZH; Cao L; Li YP
    Cochrane Database Syst Rev; 2004; (2):CD003964. PubMed ID: 15106229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-corticosteroid treatment for nephrotic syndrome in children.
    Durkan A; Hodson EM; Willis NS; Craig JC
    Cochrane Database Syst Rev; 2005 Apr; (2):CD002290. PubMed ID: 15846634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions for minimal change disease in adults with nephrotic syndrome.
    Palmer SC; Nand K; Strippoli GF
    Cochrane Database Syst Rev; 2008 Jan; 2008(1):CD001537. PubMed ID: 18253993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventions for preventing infection in nephrotic syndrome.
    Wu HM; Tang JL; Cao L; Sha ZH; Li Y
    Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD003964. PubMed ID: 22513919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of infection with different immunosuppressive drugs combined with glucocorticoids for the treatment of idiopathic membranous nephropathy: A pairwise and network meta-analysis.
    Liu D; Yang Y; Kuang F; Qing S; Hu B; Yu X
    Int Immunopharmacol; 2019 May; 70():354-361. PubMed ID: 30852290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.